Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Jul 29:2013:bcr2013009153.
doi: 10.1136/bcr-2013-009153.

Catatonic schizophrenia: therapeutic challenges and potentially a new role for electroconvulsive therapy?

Deirdre Philbin  1 , D Mulryan, M O'Grady
Affiliations
Case Reports

Catatonic schizophrenia: therapeutic challenges and potentially a new role for electroconvulsive therapy?

Deirdre Philbin et al. BMJ Case Rep. .

Abstract

A 36-year-old man with known schizophrenia, presented with increasingly bizarre behaviour. The development of catatonia and subsequent neuroleptic malignant syndrome in itself posed numerous therapeutic challenges. However, following resolution of neuroleptic malignant syndrome, the reintroduction of antipsychotics was not tolerated. This case report proposes a novel use for electroconvulsive therapy as a treatment of mental state, following resolution of neuroleptic malignant syndrome, to facilitate successful reintroduction of antipsychotics.

PubMed Disclaimer

References

    1. Swainston Harrison T, Perry CM. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Drugs 2004;2013:1715–36 - PubMed
    1. Chakraborty N, Johnston T. Aripiprazole and neuroleptic malignant syndrome. Int Clin Psychopharmacol 2004;2013:351–3 - PubMed
    1. Mizuno Y, Takubo H. Malignant syndrome in Parkinson's disease: concept and review of the literature. Parkinsonism Relat Disord 2003;2013(Suppl 1):S3–9 - PubMed
    1. Vesperini S, Papetti F. Are catatonia and neuroleptic malignant syndrome related conditions? Encephale 2010;2013:105–10 - PubMed
    1. Gurrera RJ. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome. Am J Psychiatry 1999;2013:169–80 - PubMed

Publication types

MeSH terms

Substances